Akebia Therapeutics to Present at Upcoming Investor Conferences

About this update from Akebia Therapeutics, Inc.

CAMBRIDGE, Mass. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler , Chief Executive Officer, and Erik Ostrowski , Chief Financial and Chief Business Officer, will participate in two investor conferences in November: Guggenheim 2nd Annual Healthcare Innovation Conference , taking place November 10-12, 2025 in Boston and Jefferies Global Healthcare Conference in London , taking place November 17-20, 2025 . Guggenheim Healthcare Innovation Conference Mr. Butler and Mr. Ostrowski will participate in a fireside chat on Monday, November 10 at 3:00 PM EST . Jefferies Global Healthcare Conference Mr. Butler and Mr. Ostrowski will participate in a fireside chat on Monday, November 17 at 12:00 PM GMT . A webcast of each presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conferences. About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts . For more information, please visit our website at www.akebia.com , which does not form a part of this release. Akebia Therapeutics Contact Mercedes Carrasco [email protected] Source: Akebia Therapeutics, Inc.

View stock analysis, news, and events for Akebia Therapeutics, Inc.